A quantitative and systematic review showed that ultrasonography with color Doppler is a useful preoperative test for predicting the diagnosis of pelvic masses, with a pooled sensitivity of 0.87 and a ...

A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are emerging as important for guiding ovarian cancer therapy, including ...

Only 35% of advanced cancer patients received comprehensive genomic profiling testing. Tested patients were more likely to receive targeted therapies. Testing rates increased slightly over time and ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Early detection and prevention of cancer can save lives, but current tools often fall short because of suboptimal accuracy and limited accessibility. The Fred Hutch Cancer Center aims to change that ...

In general, there are three distinct types of candidate biomarkers for hepatic cancer based on different areas: biochemical biomarkers, antigenic biomarkers and epigenetic biomarkers. Mainly the ...

Metastatic breast cancer subtypes and biomarkers are crucial for guiding treatment decisions and managing disease progression. ER-positive, HER2-negative breast cancer treatment often begins with ...

Source: Getty Images Despite proven benefits, biomarker tests remain underused in clinical practice. By examining genetic markers from urine or tissue samples, biomarkers provide a more precise ...

What are the benefits and challenges of using multiomics approaches to discover cancer biomarkers? Multiomics means that scientists are measuring more than one class of analyte, such as DNA, RNA, or ...

Since Henry Bence Jones first discovered a urine protein marker for multiple myeloma in 1846, the field of cancer biomarkers has grown exponentially. Over the past two centuries, scientists have ...